Renal function at two years in liver transplant patients receiving everolimus: Results of a randomized, multicenter study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F13%3A00058813" target="_blank" >RIV/00023001:_____/13:00058813 - isvavai.cz</a>
Result on the web
<a href="http://onlinelibrary.wiley.com/doi/10.1111/ajt.12280/pdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/ajt.12280/pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/ajt.12280" target="_blank" >10.1111/ajt.12280</a>
Alternative languages
Result language
angličtina
Original language name
Renal function at two years in liver transplant patients receiving everolimus: Results of a randomized, multicenter study
Original language description
In a 24-month prospective, randomized, multicenter, open-label study, de novo liver transplant patients were randomized at 30 days to everolimus (EVR)+Reduced tacrolimus (TAC; n=245), TAC Control (n=243) or TAC Elimination (n=231). Randomization to TAC Elimination was stopped prematurely due to a significantly higher rate of treated biopsy-proven acute rejection (tBPAR). The incidence of the primary efficacy endpoint, composite efficacy failure rate of tBPAR, graft loss or death postrandomization was similar with EVR+Reduced TAC (10.3%) or TAC Control (12.5%) at month 24 (difference -2.2%, 97.5% confidence interval [CI] -8.8%, 4.4%). BPAR was less frequent in the EVR+Reduced TAC group (6.1% vs. 13.3% in TAC Control, p=0.010). Adjusted change in estimated glomerular filtration rate (eGFR) from randomization to month 24 was superior with EVR+Reduced TAC versus TAC Control: difference 6.7mL/min/1.73m2 (97.5% CI 1.9, 11.4mL/min/1.73m2, p=0.002). Among patients who remained on treatment, me
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FJ - Surgery including transplantology
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
American journal of transplantation
ISSN
1600-6135
e-ISSN
—
Volume of the periodical
13
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
1734-1745
UT code for WoS article
000320928800017
EID of the result in the Scopus database
—